Overview

Gender

female

Monique Greer now joined in 2018 as Vice President, Corporate Communications.

Monique M. Greer joined CTI in November 2012 as Senior Vice President, Corporate Communications and Investor Relations.

Greer leads CTI’s global communications to media, investor, patient and employee audiences.

Her expertise includes corporate communications, investor and media relations, and advocacy relations in support of product development, commercialization and strategic initiatives.


Greer has more than 17 years’ strategic communications experience in the biopharmaceutical industry.

Most recently, she was Vice President of Corporate Communications and Investor Relations at Allos Therapeutics, Inc., a commercial-stage hematology/oncology biopharmaceutical company acquired by Spectrum Pharmaceuticals in September 2012.

Previously, she served as Senior Associate in the Corporate Communications and Investor Relations San Francisco practice for WCG, a global communications agency.

Greer also has served as Senior Director, Corporate Communications and Investor Relations for Dendreon Corporation, as well as Director, Corporate Communications for Heska Corporation.

Greer received a bachelor of science in Business Administration from Northeastern University, Boston.